Anti-TNF-α Therapies in Systemic Lupus Erythematosus

Suppression of tumor necrosis factor receptor associated factor (TRAF)-2 attenuates the proinflammatory and proliferative effect of aggregated IgG on rat renal mesangial cells

(2009) Lang-Jing Zhu et al.   CYTOKINE

Induction of Systemic Lupus Erythematosus with Tumor Necrosis Factor Blockers

(2009) E. SOFORO et al.   JOURNAL OF RHEUMATOLOGY

Up-regulated renal expression of TNF-α signalling adapter proteins in lupus glomerulonephritis

(2009) L Zhu et al.   LUPUS

Efficacy and safety of infliximab in active SLE: a pilot study

(2009) SS Uppal et al.   LUPUS

Adverse events and efficacy of TNF-  blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients

(2009) M. Aringer et al.   RHEUMATOLOGY

Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus

(2008) Martin Aringer et al.   Expert Opinion On Drug Safety